Clinical trial · Interventional
PACCT: Partnering Around Cancer Clinical Trials
NCT02906241CI-TRIAL-00063243completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research has the overall goal of increasing rates at which African American and White men with prostate cancer make an informed decision to participate in a cancer clinical trial.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams | Behavioral | — | UNRESOLVED |
| Physicians: Educational Module | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Patients--Intervention
- description
- Patients are randomized to an intervention group. They participate in all aspects of the study and also receive the intervention, which consists of a booklet.
- interventionNames
- Behavioral: Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams
- type
- NO_INTERVENTION
- label
- Patients--Usual Care
- description
- Patients are randomized to the standard of care arm and participate in all aspects of the study but receive no intervention.
- type
- OTHER
- label
- Physicians
- description
- Physicians receive the intervention approximately halfway through data collection for a within subjects, pre-post intervention comparison
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Physician participants Inclusion criteria: * Treat patients with prostate cancer * Able to recruit patients to clinical trials Exclusion criteria: * Do not treat patients with prostate cancer * Not able to recruit patients to clinical trials Patient Participants Inclusion criteria: * Black, African American or White; Non-hispanic confirmed diagnosis of prostate Cancer * Seeing a participating physician for less than a year and expect to see this physician at least once in the coming year * Able to read and write English well enough to understand and sign consent forms and respond to questionnaires Exclusion criteria: * Not black, African American or White; non Hispanic * No confirmed diagnosis of prostate cancer * Not seeing a participating physician or seeing a participating physician for \> than one year * Not able to read and write English well enough to understand and sign consent forms and respond to questionnaires
References
Publications (3)
- DERIVEDLiyanage JSS, Ong V, Hamel LM, Eggly S, Carducci MA, Lansey DG, Heath EI, Moore TF, Albrecht TL, Manning MA, Kim S. Interconnectedness of Factors Affecting Patient Willingness to Discuss Prostate Cancer Clinical Trials With Physicians. JCO Oncol Pract. 2026 Aug 24:OP2600036. doi: 10.1200/OP-26-00036. Online ahead of print. PMID 42636423
- DERIVEDEggly S, Manning M, Senft N, Moore TF, Albrecht TL, Penner LA, Heath E, Carducci MA, Lansey DG, Hamel LM. Development and pilot test of a physician-focused cancer clinical trials communication training intervention. PEC Innov. 2021 Dec 16;1:100012. doi: 10.1016/j.pecinn.2021.100012. eCollection 2022 Dec. PMID 37364021
- DERIVEDEggly S, Hamel LM, Heath E, Manning MA, Albrecht TL, Barton E, Wojda M, Foster T, Carducci M, Lansey D, Wang T, Abdallah R, Abrahamian N, Kim S, Senft N, Penner LA. Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials. BMC Cancer. 2017 Dec 2;17(1):807. doi: 10.1186/s12885-017-3804-5. PMID 29197371